The composite of death , any reinfarction and revascularization ( 14.5 % versus 19.3 % ; P = 0.03 ) , and cardiac death or target-vessel myocardial infarction ( 4.2 % versus 7.2 % ; P = 0.036 ) were less frequent among BES-treated patients compared with BMS-treated patients .